Field | Row 1 |
---|---|
adsh | 0001193125-25-140724 |
cik | 2007825 |
name | CHURCHILL CAPITAL CORP X/CAYMAN |
sic | 6770 |
countryba | US |
stprba | NY |
cityba | NEW YORK |
zipba | 10019 |
bas1 | 640 FIFTH AVENUE 14TH FLOOR |
bas2 | |
baph | 2123807500 |
countryma | US |
stprma | NY |
cityma | NEW YORK |
zipma | 10019 |
mas1 | 640 FIFTH AVENUE 14TH FLOOR |
mas2 | |
countryinc | KY |
stprinc | |
ein | 000000000 |
former | |
changed | |
afs | 4-NON |
wksi | 0 |
fye | 1231 |
form | 10-Q |
period | 20250331 |
fy | 2025 |
fp | Q1 |
filed | 20250613 |
accepted | 2025-06-13 16:06:00.0 |
prevrpt | 0 |
detail | 1 |
instance | d98676d10q_htm.xml |
nciks | 1 |
aciks |
Field Name | Field Description |
---|---|
adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
countryba | The ISO 3166-1 country of the registrant's business address. |
stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
cityba | The city of the registrant's business address. |
zipba | The zip code of the registrant’s business address. |
bas1 | The first line of the street of the registrant’s business address. |
bas2 | The second line of the street of the registrant’s business address. |
baph | The phone number of the registrant’s business address. |
countryma | The ISO 3166-1 country of the registrant's mailing address. |
stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
cityma | The city of the registrant's mailing address. |
zipma | The zip code of the registrant’s mailing address. |
mas1 | The first line of the street of the registrant’s mailing address. |
mas2 | The second line of the street of the registrant’s mailing address. |
countryinc | The ISO 3166-1 country of incorporation for the registrant. |
stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
former | Most recent former name of the registrant, if any. |
changed | Date of change from the former name, if any. |
afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
fye | Fiscal Year End Date, rounded to nearest month-end. |
form | The submission type of the registrant’s filing. |
period | Balance Sheet Date, rounded to nearest month-end. |
fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
filed | The date of the registrant’s filing with the Commission. |
accepted | The acceptance date and time of the registrant’s filing with the Commission. |
prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
---|---|---|---|---|---|---|---|---|---|
0001193125-25-140724 | 20241231 | Assets | 157937.0000 | USD | 0 | us-gaap/2024 | |||
0001193125-25-140724 | 20250331 | Increase Decrease In Accrued Liabilities | 0.0000 | USD | 1 | us-gaap/2024 | |||
0001193125-25-140724 | 20241231 | Retained Earnings Accumulated Deficit | -51910.0000 | USD | 0 | us-gaap/2024 | |||
0001193125-25-140724 | 20250531 | Sale Of Stock Price Per Share | 0.0001 | USD | 0 | us-gaap/2024 | Class Of Stock= Common Class B; Subsidiary Sale Of Stock= Over Allotment Option; | ||
0001193125-25-140724 | 20240331 | Shares Outstanding | 10350000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Common Class B; Equity Components= Common Stock; | ||
0001193125-25-140724 | 20241231 | Shares Outstanding | 10350000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Common Class B; Equity Components= Common Stock; | ||
0001193125-25-140724 | 20231231 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Common Class B; Equity Components= Common Stock; | ||
0001193125-25-140724 | 20240331 | Stock Issued During Period Shares New Issues | 10350000.0000 | shares | 1 | us-gaap/2024 | Class Of Stock= Common Class B; Equity Components= Common Stock; | ||
0001193125-25-140724 | 20241231 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
0001193125-25-140724 | 20250331 | Common Stock Shares Outstanding | 10350000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Founder Shares; | ||
0001193125-25-140724 | 20250331 | Deferred Offering Costs | 170882.0000 | USD | 0 | us-gaap/2024 | |||
0001193125-25-140724 | 20241231 | Liabilities And Stockholders Equity | 157937.0000 | USD | 0 | us-gaap/2024 | |||
0001193125-25-140724 | 20240331 | Net Income Loss | -44611.0000 | USD | 1 | us-gaap/2024 | |||
0001193125-25-140724 | 20250331 | Net Income Loss | -18200.0000 | USD | 1 | us-gaap/2024 | |||
0001193125-25-140724 | 20240331 | Operating Costs And Expenses | 33620.0000 | USD | 1 | us-gaap/2024 | |||
0001193125-25-140724 | 20241231 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | |||
0001193125-25-140724 | 20250430 | Sale Of Stock Number Of Shares Issued In Transaction | 41400000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Common Class B; Subsidiary Sale Of Stock= I P O; | ||
0001193125-25-140724 | 20250531 | Shares Outstanding | 10350000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Common Class B Founder Shares; Related Party Transactions By Related Party= Sponsor; | ||
0001193125-25-140724 | 20240331 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Common Class A; Equity Components= Common Stock; | ||
0001193125-25-140724 | 20240331 | Stockholders Equity | -44611.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0001193125-25-140724 | 20241231 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Common Class A; Equity Components= Common Stock; | ||
0001193125-25-140724 | 20250331 | Stockholders Equity | -70110.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0001193125-25-140724 | 20240331 | Stock Issued During Period Value New Issues | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0001193125-25-140724 | 20250331 | Assets | 170882.0000 | USD | 0 | us-gaap/2024 | |||
0001193125-25-140724 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 0.0000 | USD | 0 | us-gaap/2024 | |||
0001193125-25-140724 | 20250331 | Common Stock Shares Issued | 10350000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Founder Shares; | ||
0001193125-25-140724 | 20240331 | Deferred Offering Costs Paid By Sponsor In Exchange For Issuance Of Class B Ordinary Shares | 20173.0000 | USD | 1 | 0001193125-25-140724 | |||
0001193125-25-140724 | 20240331 | Earnings Per Share Diluted | 0.0000 | USD | 1 | us-gaap/2024 | |||
0001193125-25-140724 | 20250331 | Liabilities Current | 215992.0000 | USD | 0 | us-gaap/2024 | |||
0001193125-25-140724 | 20250331 | Notes Payable Current | 203047.0000 | USD | 0 | us-gaap/2024 | |||
0001193125-25-140724 | 20250430 | Sale Of Stock Number Of Shares Issued In Transaction | 414000000.0000 | shares | 0 | us-gaap/2024 | Subsequent Event Type= Subsequent Event; | ||
0001193125-25-140724 | 20250331 | Shares Outstanding | 10350000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Common Class B; Equity Components= Common Stock; | ||
0001193125-25-140724 | 20250430 | Stock Dividends Shares | 0.2000 | shares | 0 | us-gaap/2024 | Class Of Stock= Founder Shares; | ||
0001193125-25-140724 | 20231231 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Common Class A; Equity Components= Common Stock; | ||
0001193125-25-140724 | 20231231 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0001193125-25-140724 | 20250531 | Stock Issued During Period Shares New Issues | 1725000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Common Class B Founder Shares; Related Party Transactions By Related Party= Sponsor; | ||
0001193125-25-140724 | 20240331 | Stock Issued During Period Value New Issues | 25000.0000 | USD | 1 | us-gaap/2024 | |||
0001193125-25-140724 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 0.0000 | USD | 0 | us-gaap/2024 | |||
0001193125-25-140724 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | 0.0000 | USD | 1 | us-gaap/2024 | |||
0001193125-25-140724 | 20240131 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | Class Of Stock= Founder Shares; Related Party Transaction= Common Class B; | ||
0001193125-25-140724 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | Class Of Stock= Common Class A; | ||
0001193125-25-140724 | 20241231 | Common Stock Shares Authorized | 50000000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Common Class B; | ||
0001193125-25-140724 | 20250331 | Common Stock Shares Issued | 10350000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Common Class B; | ||
0001193125-25-140724 | 20241231 | Common Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Common Class A; | ||
0001193125-25-140724 | 20241231 | Common Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Common Class A; | ||
0001193125-25-140724 | 20250331 | Deferred Offering Costs Paid By Sponsor In Exchange For Issuance Of Class B Ordinary Shares | 0.0000 | USD | 1 | 0001193125-25-140724 | |||
0001193125-25-140724 | 20240331 | Deferred Offering Costs Paid Through Promissory Note Related Party | 118625.0000 | USD | 1 | 0001193125-25-140724 | |||
0001193125-25-140724 | 20240331 | Earnings Per Share Basic | 0.0000 | USD | 1 | us-gaap/2024 | |||
0001193125-25-140724 | 20240331 | Increase Decrease In Accrued Liabilities | 6164.0000 | USD | 1 | us-gaap/2024 | |||
0001193125-25-140724 | 20240331 | Issuance Of Stock And Warrants For Services Or Claims | 4827.0000 | USD | 1 | us-gaap/2024 | |||
0001193125-25-140724 | 20240331 | Net Cash Provided By Used In Operating Activities | 0.0000 | USD | 1 | us-gaap/2024 | |||
0001193125-25-140724 | 20241231 | Notes Payable Current | 184847.0000 | USD | 0 | us-gaap/2024 | |||
0001193125-25-140724 | 20250331 | Operating Income Loss | -18200.0000 | USD | 1 | us-gaap/2024 | |||
0001193125-25-140724 | 20241231 | Preferred Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
0001193125-25-140724 | 20250331 | Preferred Stock Shares Authorized | 5000000.0000 | shares | 0 | us-gaap/2024 | |||
0001193125-25-140724 | 20241231 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | |||
0001193125-25-140724 | 20241231 | Preferred Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
0001193125-25-140724 | 20250331 | Sale Of Stock Number Of Shares Issued In Transaction | 1350000.0000 | shares | 1 | us-gaap/2024 | Class Of Stock= Common Class B; Subsidiary Sale Of Stock= Over Allotment Option; | ||
0001193125-25-140724 | 20250331 | Sale Of Stock Number Of Shares Issued In Transaction | 300000.0000 | shares | 1 | us-gaap/2024 | Subsidiary Sale Of Stock= Private Placement; | ||
0001193125-25-140724 | 20241231 | Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Common Class A; Equity Components= Common Stock; | ||
0001193125-25-140724 | 20250531 | Shares Outstanding | 10350000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Sponsor; Related Party Transaction= Common Class B; Subsequent Event Type= Subsequent Event; | ||
0001193125-25-140724 | 20241231 | Stockholders Equity | -26910.0000 | USD | 0 | us-gaap/2024 | |||
0001193125-25-140724 | 20241231 | Stockholders Equity | 23964.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001193125-25-140724 | 20250331 | Stockholders Equity | -45110.0000 | USD | 0 | us-gaap/2024 | |||
0001193125-25-140724 | 20250331 | Stockholders Equity | 1036.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Common Class B; Equity Components= Common Stock; | ||
0001193125-25-140724 | 20240131 | Stock Issued During Period Shares Acquisitions | 7187500.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Founder Shares; Related Party Transactions By Related Party= Sponsor; | ||
0001193125-25-140724 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 9000000.0000 | shares | 1 | us-gaap/2024 | |||
0001193125-25-140724 | 20241231 | Additional Paid In Capital Common Stock | 23964.0000 | USD | 0 | us-gaap/2024 | |||
0001193125-25-140724 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 0.0000 | USD | 0 | us-gaap/2024 | |||
0001193125-25-140724 | 20240131 | Common Stock Par Or Stated Value Per Share | 0.0030 | USD | 0 | us-gaap/2024 | Class Of Stock= Sponsor; | ||
0001193125-25-140724 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | Class Of Stock= Common Class A; | ||
0001193125-25-140724 | 20250331 | Common Stock Shares Authorized | 50000000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Common Class B; | ||
0001193125-25-140724 | 20241231 | Common Stock Shares Issued | 10350000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Common Class B; | ||
0001193125-25-140724 | 20250331 | Common Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Common Class A; | ||
0001193125-25-140724 | 20250331 | Common Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Common Class A; | ||
0001193125-25-140724 | 20250331 | Operating Costs And Expenses | 18200.0000 | USD | 1 | us-gaap/2024 | |||
0001193125-25-140724 | 20250331 | Preferred Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
0001193125-25-140724 | 20250331 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | |||
0001193125-25-140724 | 20250331 | Preferred Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
0001193125-25-140724 | 20250331 | Sale Of Stock Number Of Shares Issued In Transaction | 1350000.0000 | shares | 1 | us-gaap/2024 | Class Of Stock= Founder Shares; Subsidiary Sale Of Stock= Over Allotment Option; | ||
0001193125-25-140724 | 20250430 | Sale Of Stock Number Of Shares Issued In Transaction | 5400000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Common Class B; Subsequent Event Type= Subsequent Event; Subsidiary Sale Of Stock= I P O; | ||
0001193125-25-140724 | 20250430 | Sale Of Stock Price Per Share | 10.0000 | USD | 0 | us-gaap/2024 | Subsequent Event Type= Subsequent Event; | ||
0001193125-25-140724 | 20240331 | Stockholders Equity | 23964.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001193125-25-140724 | 20250331 | Stockholders Equity | 23964.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001193125-25-140724 | 20250430 | Stock Issued During Period Shares New Issues | 1437500.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Sponsor; Related Party Transaction= Common Class B; | ||
0001193125-25-140724 | 20250531 | Stock Issued During Period Shares New Issues | 1725000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Sponsor; Related Party Transaction= Common Class B; Subsequent Event Type= Subsequent Event; | ||
0001193125-25-140724 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 9000000.0000 | shares | 1 | us-gaap/2024 | |||
0001193125-25-140724 | 20250331 | Additional Paid In Capital Common Stock | 23964.0000 | USD | 0 | us-gaap/2024 | |||
0001193125-25-140724 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | 0.0000 | USD | 1 | us-gaap/2024 | |||
0001193125-25-140724 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | Class Of Stock= Common Class B; | ||
0001193125-25-140724 | 20241231 | Common Stock Shares Authorized | 500000000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Common Class A; | ||
0001193125-25-140724 | 20250331 | Common Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Common Class A; | ||
0001193125-25-140724 | 20241231 | Common Stock Shares Outstanding | 10350000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Common Class B; | ||
0001193125-25-140724 | 20250331 | Deferred Offering Costs Paid Through Promissory Note Related Party | 0.0000 | USD | 1 | 0001193125-25-140724 | |||
0001193125-25-140724 | 20250331 | Earnings Per Share Basic | 0.0000 | USD | 1 | us-gaap/2024 | |||
0001193125-25-140724 | 20250331 | General And Administrative Expense | 18200.0000 | USD | 1 | us-gaap/2024 | |||
0001193125-25-140724 | 20250331 | Liabilities And Stockholders Equity | 170882.0000 | USD | 0 | us-gaap/2024 | |||
0001193125-25-140724 | 20250331 | Net Cash Provided By Used In Operating Activities | 0.0000 | USD | 1 | us-gaap/2024 | |||
0001193125-25-140724 | 20250331 | Sale Of Stock Number Of Shares Issued In Transaction | 5400000.0000 | shares | 1 | us-gaap/2024 | Subsidiary Sale Of Stock= I P O; | ||
0001193125-25-140724 | 20250430 | Sale Of Stock Number Of Shares Issued In Transaction | 1350000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Common Class B; Subsidiary Sale Of Stock= Over Allotment Option; | ||
0001193125-25-140724 | 20231231 | Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Common Class B; Equity Components= Common Stock; | ||
0001193125-25-140724 | 20240331 | Stockholders Equity | 1036.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Common Class B; Equity Components= Common Stock; | ||
0001193125-25-140724 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 9000000.0000 | shares | 1 | us-gaap/2024 | |||
0001193125-25-140724 | 20240131 | Common Stock Value | 25000.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Sponsor; | ||
0001193125-25-140724 | 20250331 | Accrued Offering Costs Current | 12945.0000 | USD | 0 | 0001193125-25-140724 | |||
0001193125-25-140724 | 20250331 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
0001193125-25-140724 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | Class Of Stock= Common Class B; | ||
0001193125-25-140724 | 20250331 | Common Stock Shares Authorized | 500000000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Common Class A; | ||
0001193125-25-140724 | 20240131 | Common Stock Shares Issued | 7187500.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Founder Shares; Related Party Transaction= Common Class B; | ||
0001193125-25-140724 | 20250331 | Common Stock Value | 1036.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Common Class B; | Includes an aggregate of up to 1,350,000 Class B ordinary shares, $0.0001 par value subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (Note 5). On May 15, 2025, the Company consummated its Initial Public Offering and sold 41.4 million Units, which includes the full exercise of the underwriters over-allotment option, hence the 1,350,000 Class B ordinary shares are no longer subject to forfeiture. | On February 15, 2024, the Sponsor acquired an aggrega | |
0001193125-25-140724 | 20240331 | Deferred Offering Costs Included In Accrued Offering Costs | 9845.0000 | USD | 1 | 0001193125-25-140724 | |||
0001193125-25-140724 | 20250331 | Deferred Offering Costs Included In Accrued Offering Costs | 12945.0000 | USD | 1 | 0001193125-25-140724 | |||
0001193125-25-140724 | 20250331 | Issuance Of Stock And Warrants For Services Or Claims | USD | 1 | us-gaap/2024 | ||||
0001193125-25-140724 | 20241231 | Liabilities Current | 184847.0000 | USD | 0 | us-gaap/2024 | |||
0001193125-25-140724 | 20250331 | Net Income Loss | -18200.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0001193125-25-140724 | 20240331 | Operating Income Loss | -44611.0000 | USD | 1 | us-gaap/2024 | |||
0001193125-25-140724 | 20241231 | Preferred Stock Shares Authorized | 5000000.0000 | shares | 0 | us-gaap/2024 | |||
0001193125-25-140724 | 20231231 | Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Common Class A; Equity Components= Common Stock; | ||
0001193125-25-140724 | 20240331 | Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Common Class A; Equity Components= Common Stock; | ||
0001193125-25-140724 | 20250331 | Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Common Class A; Equity Components= Common Stock; | ||
0001193125-25-140724 | 20231231 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001193125-25-140724 | 20240331 | Stockholders Equity | -19611.0000 | USD | 0 | us-gaap/2024 | |||
0001193125-25-140724 | 20241231 | Stockholders Equity | -51910.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0001193125-25-140724 | 20240331 | Stock Issued During Period Value New Issues | 23964.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001193125-25-140724 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 9000000.0000 | shares | 1 | us-gaap/2024 | |||
0001193125-25-140724 | 20241231 | Accrued Offering Costs Current | 0.0000 | USD | 0 | 0001193125-25-140724 | |||
0001193125-25-140724 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 0.0000 | USD | 0 | us-gaap/2024 | |||
0001193125-25-140724 | 20241231 | Common Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Common Class A; | ||
0001193125-25-140724 | 20241231 | Common Stock Shares Issued | 10350000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Founder Shares; | ||
0001193125-25-140724 | 20241231 | Common Stock Shares Outstanding | 10350000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Founder Shares; | ||
0001193125-25-140724 | 20250331 | Common Stock Shares Outstanding | 10350000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Common Class B; | ||
0001193125-25-140724 | 20241231 | Common Stock Value | 1036.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Common Class B; | ||
0001193125-25-140724 | 20241231 | Deferred Offering Costs | 157937.0000 | USD | 0 | us-gaap/2024 | |||
0001193125-25-140724 | 20250331 | Earnings Per Share Diluted | 0.0000 | USD | 1 | us-gaap/2024 | |||
0001193125-25-140724 | 20240331 | General And Administrative Expense | 44611.0000 | USD | 1 | us-gaap/2024 | |||
0001193125-25-140724 | 20240331 | Net Income Loss | -44611.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0001193125-25-140724 | 20250331 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | |||
0001193125-25-140724 | 20250331 | Retained Earnings Accumulated Deficit | -70110.0000 | USD | 0 | us-gaap/2024 | |||
0001193125-25-140724 | 20250430 | Sale Of Stock Number Of Shares Issued In Transaction | 300000.0000 | shares | 0 | us-gaap/2024 | Subsequent Event Type= Subsequent Event; Subsidiary Sale Of Stock= Private Placement; | ||
0001193125-25-140724 | 20250331 | Sale Of Stock Price Per Share | 0.0001 | USD | 0 | us-gaap/2024 | Class Of Stock= Common Class B; Subsidiary Sale Of Stock= Over Allotment Option; | ||
0001193125-25-140724 | 20231231 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | |||
0001193125-25-140724 | 20241231 | Stockholders Equity | 1036.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Common Class B; Equity Components= Common Stock; | ||
0001193125-25-140724 | 20250331 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Common Class A; Equity Components= Common Stock; | ||
0001193125-25-140724 | 20240331 | Stock Issued During Period Value New Issues | 1036.0000 | USD | 1 | us-gaap/2024 | Class Of Stock= Common Class B; Equity Components= Common Stock; | ||
0001193125-25-140724 | 20240131 | Treasury Stock Acquired Average Cost Per Share | 0.0030 | USD | 0 | us-gaap/2024 | Class Of Stock= Founder Shares; Related Party Transactions By Related Party= Sponsor; |
Field Name | Field Description |
---|---|
adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
tag | The unique identifier (name) for a tag in a specific taxonomy release. |
version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
ddate | The end date for the data value, rounded to the nearest month end. |
qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
uom | The unit of measure for the value. |
segments | Tags used to represent axis and member reporting. |
coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
---|---|---|---|---|---|---|---|---|
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
Deferred Offering Costs Paid By Sponsor In Exchange For Issuance Of Class B Ordinary Shares | 0001193125-25-140724 | 1 | 0 | monetary | D | C | Deferred Offering Costs Paid By Sponsor In Exchange For Issuance Of Class B Ordinary Shares | Deferred offering costs paid by sponsor in exchange for issuance of class B ordinary shares. |
Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
Common Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
Sale Of Stock Price Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Sale of Stock, Price Per Share | Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. | |
Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
Treasury Stock Acquired Average Cost Per Share | us-gaap/2024 | 0 | 0 | perShare | D | Shares Acquired, Average Cost Per Share | Total cost of shares repurchased divided by the total number of shares repurchased. | |
Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
Preferred Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Issued | Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt. | |
Sale Of Stock Number Of Shares Issued In Transaction | us-gaap/2024 | 0 | 0 | shares | D | Sale of Stock, Number of Shares Issued in Transaction | The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. | |
Increase Decrease In Accrued Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accrued Liabilities | The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid. |
Preferred Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Preferred Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. |
Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
Notes Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Notes Payable, Current | Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer. |
Operating Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
Deferred Offering Costs | us-gaap/2024 | 0 | 0 | monetary | I | D | Deferred Offering Costs | Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period. |
General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
Stock Issued During Period Shares New Issues | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, New Issues | Number of new stock issued during the period. | |
Accrued Offering Costs Current | 0001193125-25-140724 | 1 | 0 | monetary | I | C | Accrued Offering Costs Current | Accrued offering costs current. |
Deferred Offering Costs Included In Accrued Offering Costs | 0001193125-25-140724 | 1 | 0 | monetary | D | C | Deferred Offering Costs Included In Accrued Offering Costs | Deferred Offering costs included in accrued offering costs. |
Additional Paid In Capital Common Stock | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital, Common Stock | Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital. |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
Commitments And Contingencies | us-gaap/2024 | 0 | 0 | monetary | I | C | Commitments and Contingencies | Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. |
Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
Operating Costs And Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Costs and Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense. |
Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Preferred Stock, Par or Stated Value Per Share | Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. | |
Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
Preferred Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Authorized | The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. | |
Preferred Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Outstanding | Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. | |
Stock Dividends Shares | us-gaap/2024 | 0 | 0 | shares | D | Stock Dividends, Shares | Number of shares of common and preferred stock issued as dividends during the period. Excludes stock splits. | |
Stock Issued During Period Value New Issues | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, New Issues | Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. |
Deferred Offering Costs Paid Through Promissory Note Related Party | 0001193125-25-140724 | 1 | 0 | monetary | D | C | Deferred Offering Costs Paid Through Promissory Note Related Party | Deferred offering costs paid through promissory note related party. |
Issuance Of Stock And Warrants For Services Or Claims | us-gaap/2024 | 0 | 0 | monetary | D | D | Issuance of Stock and Warrants for Services or Claims | Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims. |
Stock Issued During Period Shares Acquisitions | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Acquisitions | Number of shares of stock issued during the period pursuant to acquisitions. | |
Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. |
Field Name | Field Description |
---|---|
tag | The unique identifier (name) for a tag in a specific taxonomy release. |
version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
abstract | 1 if the tag is not used to represent a numeric fact. |
datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
---|---|---|---|---|---|---|---|---|---|
0001193125-25-140724 | 2 | 25 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total Shareholder's Deficit | 0 |
0001193125-25-140724 | 8 | 16 | CF | 0 | H | Deferred Offering Costs Paid By Sponsor In Exchange For Issuance Of Class B Ordinary Shares | 0001193125-25-140724 | Deferred Offering Costs Paid By Sponsor In Exchange For Issuance Of Class B Ordinary Shares | 0 |
0001193125-25-140724 | 2 | 11 | BS | 0 | H | Deferred Offering Costs | us-gaap/2024 | Deferred Offering Costs | 0 |
0001193125-25-140724 | 2 | 12 | BS | 0 | H | Assets | us-gaap/2024 | Total Assets | 0 |
0001193125-25-140724 | 2 | 15 | BS | 0 | H | Accrued Offering Costs Current | 0001193125-25-140724 | Accrued offering costs | 0 |
0001193125-25-140724 | 2 | 16 | BS | 0 | H | Notes Payable Current | us-gaap/2024 | Promissory note - related party | 0 |
0001193125-25-140724 | 2 | 18 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total Current Liabilities | 0 |
0001193125-25-140724 | 2 | 19 | BS | 0 | H | Commitments And Contingencies | us-gaap/2024 | Commitments and Contingencies (Note 6) | 0 |
0001193125-25-140724 | 2 | 21 | BS | 0 | H | Preferred Stock Value | us-gaap/2024 | Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued or outstanding | 0 |
0001193125-25-140724 | 2 | 22 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common Stock | 0 |
0001193125-25-140724 | 2 | 23 | BS | 0 | H | Additional Paid In Capital Common Stock | us-gaap/2024 | Additional paid-in capital | 0 |
0001193125-25-140724 | 2 | 24 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 1 |
0001193125-25-140724 | 2 | 26 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | Total Liabilities and Shareholder's Deficit | 0 |
0001193125-25-140724 | 3 | 18 | BS | 1 | H | Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | Preferred stock, par value | 0 |
0001193125-25-140724 | 3 | 19 | BS | 1 | H | Preferred Stock Shares Authorized | us-gaap/2024 | Preferred stock, shares authorized | 0 |
0001193125-25-140724 | 3 | 20 | BS | 1 | H | Preferred Stock Shares Issued | us-gaap/2024 | Preferred stock, shares issued | 0 |
0001193125-25-140724 | 3 | 21 | BS | 1 | H | Preferred Stock Shares Outstanding | us-gaap/2024 | Preferred stock, shares outstanding | 0 |
0001193125-25-140724 | 3 | 22 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Common stock, par value | 0 |
0001193125-25-140724 | 3 | 23 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common stock, shares authorized | 0 |
0001193125-25-140724 | 3 | 24 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common stock, shares issued | 0 |
0001193125-25-140724 | 3 | 25 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common stock, shares outstanding | 0 |
0001193125-25-140724 | 3 | 26 | BS | 1 | H | Sale Of Stock Number Of Shares Issued In Transaction | us-gaap/2024 | Sale of stock, number of shares issued in transaction | 0 |
0001193125-25-140724 | 3 | 27 | BS | 1 | H | Sale Of Stock Price Per Share | us-gaap/2024 | Sale of stock, price per share | 0 |
0001193125-25-140724 | 3 | 28 | BS | 1 | H | Stock Issued During Period Shares Acquisitions | us-gaap/2024 | Stock issued during period, shares, acquisitions | 0 |
0001193125-25-140724 | 3 | 29 | BS | 1 | H | Treasury Stock Acquired Average Cost Per Share | us-gaap/2024 | Shares acquired, average cost per share | 0 |
0001193125-25-140724 | 3 | 30 | BS | 1 | H | Stock Dividends Shares | us-gaap/2024 | Stock dividends, shares | 0 |
0001193125-25-140724 | 3 | 31 | BS | 1 | H | Stock Issued During Period Shares New Issues | us-gaap/2024 | Stock issued during period, shares, new issues | 0 |
0001193125-25-140724 | 3 | 32 | BS | 1 | H | Shares Outstanding | us-gaap/2024 | Shares, outstanding | 0 |
0001193125-25-140724 | 4 | 9 | IS | 0 | H | General And Administrative Expense | us-gaap/2024 | General and administrative costs | 0 |
0001193125-25-140724 | 4 | 10 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | Loss from operations | 0 |
0001193125-25-140724 | 4 | 11 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
0001193125-25-140724 | 4 | 12 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Basic net income per share | 0 |
0001193125-25-140724 | 4 | 13 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Diluted net income per share | 0 |
0001193125-25-140724 | 4 | 14 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | Basic weighted average shares outstanding | 0 |
0001193125-25-140724 | 4 | 15 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Diluted weighted average shares outstanding | 0 |
0001193125-25-140724 | 5 | 15 | IS | 1 | H | Sale Of Stock Number Of Shares Issued In Transaction | us-gaap/2024 | Sale of stock, number of shares issued in transaction | 0 |
0001193125-25-140724 | 5 | 16 | IS | 1 | H | Stock Issued During Period Shares Acquisitions | us-gaap/2024 | Stock issued during period, shares, acquisitions | 0 |
0001193125-25-140724 | 5 | 17 | IS | 1 | H | Sale Of Stock Price Per Share | us-gaap/2024 | Sale of stock, price per share | 0 |
0001193125-25-140724 | 5 | 18 | IS | 1 | H | Stock Dividends Shares | us-gaap/2024 | Stock dividends, shares | 0 |
0001193125-25-140724 | 5 | 19 | IS | 1 | H | Stock Issued During Period Shares New Issues | us-gaap/2024 | Stock issued during period, shares, new issues | 0 |
0001193125-25-140724 | 5 | 20 | IS | 1 | H | Shares Outstanding | us-gaap/2024 | Shares, outstanding | 0 |
0001193125-25-140724 | 5 | 21 | IS | 1 | H | Treasury Stock Acquired Average Cost Per Share | us-gaap/2024 | Shares acquired, average cost per share | 0 |
0001193125-25-140724 | 6 | 12 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Beginning balance | 0 |
0001193125-25-140724 | 6 | 13 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Beginning balance (shares) | 0 |
0001193125-25-140724 | 6 | 14 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
0001193125-25-140724 | 6 | 15 | EQ | 0 | H | Stock Issued During Period Value New Issues | us-gaap/2024 | Issuance of Class B ordinary shares to Sponsor | 0 |
0001193125-25-140724 | 6 | 16 | EQ | 0 | H | Stock Issued During Period Shares New Issues | us-gaap/2024 | Issuance of Class B ordinary shares to Sponsor (shares) | 0 |
0001193125-25-140724 | 6 | 17 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Ending balance | 0 |
0001193125-25-140724 | 6 | 18 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Ending balance (shares) | 0 |
0001193125-25-140724 | 7 | 15 | EQ | 1 | H | Sale Of Stock Number Of Shares Issued In Transaction | us-gaap/2024 | Sale of stock, number of shares issued in transaction | 0 |
0001193125-25-140724 | 7 | 16 | EQ | 1 | H | Sale Of Stock Price Per Share | us-gaap/2024 | Sale of stock, price per share | 0 |
0001193125-25-140724 | 7 | 17 | EQ | 1 | H | Stock Issued During Period Shares Acquisitions | us-gaap/2024 | Stock issued during period, shares, acquisitions | 0 |
0001193125-25-140724 | 7 | 18 | EQ | 1 | H | Treasury Stock Acquired Average Cost Per Share | us-gaap/2024 | Shares acquired, average cost per share | 0 |
0001193125-25-140724 | 7 | 19 | EQ | 1 | H | Stock Dividends Shares | us-gaap/2024 | Stock dividends, shares | 0 |
0001193125-25-140724 | 7 | 20 | EQ | 1 | H | Stock Issued During Period Shares New Issues | us-gaap/2024 | Stock issued during period, shares, new issues | 0 |
0001193125-25-140724 | 7 | 21 | EQ | 1 | H | Shares Outstanding | us-gaap/2024 | Shares, outstanding | 0 |
0001193125-25-140724 | 8 | 2 | CF | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
0001193125-25-140724 | 8 | 4 | CF | 0 | H | Operating Costs And Expenses | us-gaap/2024 | Payment of expense through promissory note related party | 0 |
0001193125-25-140724 | 8 | 6 | CF | 0 | H | Issuance Of Stock And Warrants For Services Or Claims | us-gaap/2024 | Payment of formation costs through issuance of Class B ordinary shares | 0 |
0001193125-25-140724 | 8 | 8 | CF | 0 | H | Increase Decrease In Accrued Liabilities | us-gaap/2024 | Accrued expenses | 0 |
0001193125-25-140724 | 8 | 9 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net cash used in operating activities | 0 |
0001193125-25-140724 | 8 | 10 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | Net Change in Cash | 0 |
0001193125-25-140724 | 8 | 11 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash Beginning of period | 0 |
0001193125-25-140724 | 8 | 12 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash End of period | 0 |
0001193125-25-140724 | 8 | 14 | CF | 0 | H | Deferred Offering Costs Included In Accrued Offering Costs | 0001193125-25-140724 | Deferred offering costs included in accrued offerings costs | 0 |
0001193125-25-140724 | 8 | 15 | CF | 0 | H | Deferred Offering Costs Paid Through Promissory Note Related Party | 0001193125-25-140724 | Deferred offering costs paid through promissory note related party | 0 |
Field Name | Field Description |
---|---|
adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
stmt | The financial statement location to which the value of the “report” field pertains. |
inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
tag | The tag chosen by the filer for this line item. |
version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
plabel | The text presented on the line item, also known as a “preferred” label. |
negating | Flag to indicate whether the plabel is negating. |